SMS Lifesciences Share Price
SMS Lifesciences Share Price Today
As of 5 Jul 2026, SMS Lifesciences share price is ₹1,655.00. The stock opened at ₹1,630.00, compared to its previous close of ₹1,630.90. During today's trading session, SMS Lifesciences share price moved in the range of ₹1,630.00 to ₹1,680.00, with an average price of ₹1,655.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,067.00 and a high of ₹1,774.00. On the performance front, SMS Lifesciences share price has increased by 22.36% over the last six months and is up 40.96% on a year-on-year basis.
SMS Lifesciences Returns Calculator
SMS Lifesciences Shareholder Returns
SMS Lifesciences Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
SMS Lifesciences Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹344.72 | ₹305.96 | ₹315.56 | ₹350.07 |
| Other Income | ₹4.86 | ₹3.83 | ₹3.07 | ₹1.74 |
| Total Revenue | ₹349.58 | ₹309.79 | ₹318.63 | ₹351.81 |
| Total Expenses | ₹323.39 | ₹299.94 | ₹304.39 | ₹331.77 |
| Profit Before Tax | ₹26.19 | ₹9.85 | ₹16.59 | ₹32.73 |
| Tax | ₹7.46 | ₹3.52 | ₹5.22 | ₹7.43 |
| Profit After Tax | ₹18.73 | ₹6.33 | ₹11.38 | ₹25.30 |
| EPS - Basic | ₹66.51 | ₹30.08 | ₹37.92 | ₹83.76 |
| EPS - Diluted | ₹66.51 | ₹30.08 | ₹37.92 | ₹83.76 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹26.19 | ₹9.85 | ₹14.24 | ₹20.04 |
| Income before WC changes | ₹50.91 | ₹31.33 | ₹30.11 | ₹34.09 |
| Change in Assets | -₹49.93 | -₹40.32 | -₹31.16 | -₹52.44 |
| Change in Liabilities | ₹41.57 | ₹36.30 | ₹19.01 | ₹14.82 |
| Change in WC | -₹8.36 | -₹4.03 | -₹12.15 | -₹37.62 |
| Cash flow from Operations | ₹34.06 | ₹24.31 | ₹14.70 | -₹11.24 |
| Cash flow from Investing | -₹15.00 | -₹18.45 | -₹31.29 | -₹7.14 |
| Cash flow from Financing | -₹19.12 | -₹6.56 | ₹16.89 | ₹10.83 |
| Total Cash Flow | -₹0.07 | -₹0.71 | ₹0.29 | -₹7.55 |
| Cash (Start of the year) | ₹0.57 | ₹1.28 | ₹0.99 | ₹8.54 |
| Cash (End of the year) | ₹0.50 | ₹0.57 | ₹1.28 | ₹0.99 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹239.42 | ₹235.25 | ₹235.77 | ₹200.73 |
| Current Assets | ₹150.57 | ₹156.08 | ₹159.12 | ₹156.02 |
| Total Assets | ₹389.99 | ₹391.33 | ₹394.89 | ₹356.75 |
| Current Liabilities | ₹142.07 | ₹145.37 | ₹133.56 | ₹135.44 |
| Net Current Asset | ₹8.51 | ₹10.71 | ₹25.55 | ₹20.58 |
| Non-Current Liabilities | ₹35.88 | ₹52.32 | ₹73.11 | ₹56.38 |
| Equity Capital | ₹212.05 | ₹193.64 | ₹188.22 | ₹164.93 |
| Total Equity & Liabilities | ₹389.99 | ₹391.33 | ₹394.89 | ₹356.75 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹333.37 | ₹300.00 | ₹315.24 | ₹345.63 |
| Other Income | ₹3.95 | ₹3.84 | ₹2.88 | ₹1.54 |
| Total Revenue | ₹337.32 | ₹303.84 | ₹318.12 | ₹347.16 |
| Total Expenses | ₹307.28 | ₹284.73 | ₹302.10 | ₹326.88 |
| Profit Before Tax | ₹30.04 | ₹19.11 | ₹18.37 | ₹32.98 |
| Tax | ₹8.67 | ₹6.05 | ₹5.15 | ₹7.60 |
| Profit After Tax | ₹21.37 | ₹13.07 | ₹13.22 | ₹25.38 |
| EPS - Basic | ₹70.69 | ₹43.22 | ₹43.72 | ₹83.95 |
| EPS - Diluted | ₹70.69 | ₹43.22 | ₹43.72 | ₹83.95 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹30.04 | ₹19.11 | ₹16.02 | ₹20.28 |
| Income before WC changes | ₹48.89 | ₹34.51 | ₹27.53 | ₹30.80 |
| Change in Assets | -₹9.82 | -₹6.97 | -₹7.49 | -₹34.55 |
| Change in Liabilities | -₹2.54 | -₹9.79 | -₹11.97 | -₹3.34 |
| Change in WC | -₹12.36 | -₹16.76 | -₹19.45 | -₹37.90 |
| Cash flow from Operations | ₹28.03 | ₹14.75 | ₹4.58 | -₹14.66 |
| Cash flow from Investing | -₹13.77 | -₹13.75 | -₹27.96 | -₹7.49 |
| Cash flow from Financing | -₹14.20 | -₹0.82 | ₹22.59 | ₹14.63 |
| Total Cash Flow | ₹0.07 | ₹0.18 | -₹0.80 | -₹7.52 |
| Cash (Start of the year) | ₹0.33 | ₹0.15 | ₹0.95 | ₹8.46 |
| Cash (End of the year) | ₹0.40 | ₹0.33 | ₹0.15 | ₹0.95 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹180.52 | ₹172.88 | ₹169.80 | ₹149.68 |
| Current Assets | ₹177.79 | ₹175.35 | ₹167.59 | ₹162.32 |
| Total Assets | ₹358.31 | ₹348.24 | ₹337.39 | ₹312.00 |
| Current Liabilities | ₹124.30 | ₹123.56 | ₹110.57 | ₹118.96 |
| Net Current Asset | ₹53.49 | ₹51.79 | ₹57.03 | ₹43.35 |
| Non-Current Liabilities | ₹36.84 | ₹48.45 | ₹62.80 | ₹41.83 |
| Equity Capital | ₹197.18 | ₹176.23 | ₹164.03 | ₹151.21 |
| Total Equity & Liabilities | ₹358.31 | ₹348.24 | ₹337.39 | ₹312.00 |
About SMS Lifesciences
Haleos Labs Limited, formerly, SMS Lifesciences India Limited, is an India-based company that is engaged in the business of manufacturing of active pharma ingredients (API) and their intermediates. The Company's API products include Ranitidine Hydrochloride (Form-2) USP / Ph. Eur / IP, Famotidine USP / Ph. Eur / IP, Sildenafil Citrate USP / Ph. Eur / IP, Allopurinol USP / EP / IP, Ropivacaine Hydrochloride USP / EP / IP, Dapsone USP/ EP /BP, Sibutramine Hydrochloride USP, Itraconazole USP / Ph. Eur, Fosphenytoin Sodium USP, Domperidone / Domperidone Maleate EP / IP, Brinzolamide, Tiagabine, Fosaprepitant and Albendazole, among others. Its intermediate offerings include Ranitidine HCl Intermediates, Rizatriptan Intermediates and Imidapril Intermediates. The Company's manufacturing facilities are located at Kazipally and Jeedimetla, and its research and development center is at Sanath Nagar in Hyderabad. The Company's wholly owned subsidiary is Mahi Drugs Private Limited.
SMS Lifesciences Financial Highlights
- Revenue: SMS Lifesciences reported revenue of ₹336.22 crore in FY26 vs ₹349.58 crore in FY25. It showed a decrease of 3.82% on a yearly basis.
- Operating Profit: SMS Lifesciences reported an operating profit of ₹25.20 crore in FY26 vs ₹26.19 crore in FY25. It showed a decrease of 3.78% on a year-on-year basis.
- Net Profit: SMS Lifesciences reported a net profit of ₹17.80 crore in FY26 vs ₹18.73 crore in FY25. It showed a decrease of 4.97% on a yearly basis.
SMS Lifesciences Quarterly Result Highlights
- SMS Lifesciences reported revenue of ₹77.15 crore in Mar 2026, compared with ₹94.96 crore in Dec 2025, representing a decrease of 18.76% on a quarter-on-quarter (QoQ) basis.
- SMS Lifesciences reported an operating profit of ₹0.91 crore in Mar 2026, compared with ₹8.78 crore in Dec 2025, representing a decrease of 89.64% on a quarter-on-quarter (QoQ) basis.
- SMS Lifesciences reported a profit of ₹0.34 crore in Mar 2026, compared with ₹6.65 crore in Dec 2025, reflecting a decrease of 94.89% on a QoQ basis.
- The earnings per share (EPS) of SMS Lifesciences stood at ₹66.51 during Mar 2026.
Similar Stocks
FAQs on SMS Lifesciences Share Price
What is SMS Lifesciences share price today?
SMS Lifesciences share price is ₹1,655.00 as on 03 Jul, 2026, 15:29 IST.
How has the SMS Lifesciences share price performed in the past?
In the last 1 year, SMS Lifesciences delivered a return of 40.96%. The SMS Lifesciences share price hit a high of ₹1,774.00 and low of ₹1,067.00.
How much is the Mutual Fund shareholding in SMS Lifesciences shares?
The Mutual Fund Shareholding in SMS Lifesciences was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of SMS Lifesciences shares ?
The 52-week high and low of SMS Lifesciences share is ₹1,774.00 and ₹1,067.00 as of 03 Jul, 2026.
What is the market cap of SMS Lifesciences?
The market capitalisation of SMS Lifesciences is ₹492.99 Crores as on 03 Jul, 2026.
What are the stock symbols of SMS Lifesciences?
The stock symbol of SMS Lifesciences is HALEOSLABS on the NSE, 540679 on the BSE, and the ISIN is INE320X01016.
What was yesterday's closing price of SMS Lifesciences shares ?
SMS Lifesciences shares closed yesterday at ₹1,630.90 on NSE & ₹1,630.65 on BSE
How to buy SMS Lifesciences shares?
To buy SMS Lifesciences shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy SMS Lifesciences shares on Holidays?
No, shares of SMS Lifesciences or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell SMS Lifesciences shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of SMS Lifesciences?
The PE and PB ratio of SMS Lifesciences is 27.69 and 2.31 respectively, as on 03 Jul, 2026, 15:29 IST.